2-(3-Azabicyclo[3.1.0]hex-3-yl)-5-aminopyridine → N-[6-(3-Azabicyclo[3.1.0]hex-3-yl)pyridin-3-yl]-5-trifluoromethyl-1-(3-fluorobenzyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxamide

HRID 1019554Notes

Reaction equation

HRID 1019554 reaction equation
[F:1][C:2]([F:24])([F:23])[C:3]1[CH:4]=[C:5]2[CH:11]=[C:10]([C:12](O)=[O:13])[N:9]([CH2:15][C:16]3[CH:21]=[CH:20][CH:19]=[C:18]([F:22])[CH:17]=3)[C:6]2=[N:7][CH:8]=1.[CH:25]12[CH2:30][CH:29]1[CH2:28][N:27]([C:31]1[N:36]=[CH:35][C:34]([NH2:37])=[CH:33][CH:32]=1)[CH2:26]2>>[CH:29]12[CH2:30][CH:25]1[CH2:26][N:27]([C:31]1[N:36]=[CH:35][C:34]([NH:37][C:12]([C:10]3[N:9]([CH2:15][C:16]4[CH:21]=[CH:20][CH:19]=[C:18]([F:22])[CH:17]=4)[C:6]4=[N:7][CH:8]=[C:3]([C:2]([F:24])([F:1])[F:23])[CH:4]=[C:5]4[CH:11]=3)=[O:13])=[CH:33][CH:32]=1)[CH2:28]2

Participants

3

Procedure

According to a method similar to that described in Stage 12.3, starting from 0.5 g (1.48 mmol) of 5-trifluoromethyl-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, described in Stage 1.3, and 0.3 g (1.71 mmol) of 6-(3-azabicyclo[3.1.0]hex-3-yl)-3-aminopyridine, prepared in the preceding stage, we obtain 0.233 g of the expected product.

Workup

  1. customprepared in the preceding stage, we

Sources & evidence

ORD record
ord-1ece1859ac1147cd8d2197a8c5b24fa9
Source dataset
uspto-grants-2014_05
Patent number
US08716272B2

Reaction notes

Loading…